May 13, 2026 EASO Updates Obesity Treatment Algorithm With 2026 Evidence for Weight Loss & Liver Disease
February 24, 2026 Gaylussacin Inhibits COPD Progression by Targeting CK2-Mediated CTCF Activation in Macrophages